Study: Use of Renin–angiotensin–aldosterone System Inhibitors Does Not Increase the Risk of COVID-19 Requiring Admission to Hospital
18 May, 2020 | 01:45h | UTCCommentary: Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19 – The Lancet